123 related articles for article (PubMed ID: 5001511)
21. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
22. Identification of Brucella abortus strain 19 by decreased ability to utilize erythritol as determined by gas liquid chromatography.
Ewalt DR; Ross PF; Payeur JB
J Vet Diagn Invest; 1990 Apr; 2(2):120-2. PubMed ID: 2128815
[TBL] [Abstract][Full Text] [Related]
23. Production of the siderophore 2,3-dihydroxybenzoic acid is required for wild-type growth of Brucella abortus in the presence of erythritol under low-iron conditions in vitro.
Bellaire BH; Elzer PH; Baldwin CL; Roop RM
Infect Immun; 2003 May; 71(5):2927-832. PubMed ID: 12704172
[TBL] [Abstract][Full Text] [Related]
24. Effect of erythritol on different strains of Brucella melitensis.
Joshi DV; Prakash O
Indian J Pathol Bacteriol; 1970 Oct; 13(4):166-72. PubMed ID: 5522254
[No Abstract] [Full Text] [Related]
25. A purified killed Brucella abortus vaccine.
Keppie J; Witt K; Smith H
Br J Exp Pathol; 1971 Aug; 52(4):365-70. PubMed ID: 4998841
[TBL] [Abstract][Full Text] [Related]
26. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM
Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382
[TBL] [Abstract][Full Text] [Related]
27. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
Wallach JC; Ferrero MC; Victoria Delpino M; Fossati CA; Baldi PC
Clin Microbiol Infect; 2008 Aug; 14(8):805-7. PubMed ID: 18727806
[TBL] [Abstract][Full Text] [Related]
28. Foetal erythritol: a cause of the localization of Brucella abortus in bovine contagious abortion.
SMITH H; WILLIAMS AE; PEARCE JH; KEPPIE J; HARRIS-SMITH PW; FITZ-GEORGE RB; WITT K
Nature; 1962 Jan; 193():47-9. PubMed ID: 13914250
[No Abstract] [Full Text] [Related]
29. [Experiment planning for optimizing the stab cultivation of brucellae].
Nikanorov BA; Tarakanov IuI; Raushenbakh GV; Shishov VP
Veterinariia; 1978 Feb; (2):45-50. PubMed ID: 416556
[No Abstract] [Full Text] [Related]
30. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the effects of erythritol on gene expression in Brucella abortus.
Rodríguez MC; Viadas C; Seoane A; Sangari FJ; López-Goñi I; García-Lobo JM
PLoS One; 2012; 7(12):e50876. PubMed ID: 23272076
[TBL] [Abstract][Full Text] [Related]
32. Early appearance of colonies of Brucella spp. on solid media containing erythritol.
Keppie J; Witt KA; Smith H
J Appl Bacteriol; 1966 Dec; 29(3):556-8. PubMed ID: 5980919
[No Abstract] [Full Text] [Related]
33. The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice.
Sangari FJ; Grilló MJ; Jiménez De Bagüés MP; González-Carreró MI; García-Lobo JM; Blasco JM; Agüero J
Vaccine; 1998 Oct; 16(17):1640-5. PubMed ID: 9713940
[TBL] [Abstract][Full Text] [Related]
34. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
[TBL] [Abstract][Full Text] [Related]
35. Laboratory maintenance of Brucella abortus.
Sun YH; den Hartigh AB; Tsolis RM; Ficht TA
Curr Protoc Microbiol; 2005 Oct; Chapter 3():Unit 3B.1. PubMed ID: 18770565
[TBL] [Abstract][Full Text] [Related]
36. Human exposure to Brucella abortus strain RB51--Kansas, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(9):172-5. PubMed ID: 9518281
[TBL] [Abstract][Full Text] [Related]
37. The characteristics of "Brucella ovis" (New Zealand).
Parnas J
Ann Sclavo; 1971; 13(4):490-8. PubMed ID: 5005103
[No Abstract] [Full Text] [Related]
38. Metabolic characterization of the genus Brucella. VI. Growth stimulation by i-erythritol compared with strain virulence for guinea pigs.
Meyer ME
J Bacteriol; 1967 Mar; 93(3):996-1000. PubMed ID: 4960927
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of various media and the use of soil infusion in the production of Brucella abortus antigen.
Garcia MM
Can J Comp Med; 1973 Jan; 37(1):33-42. PubMed ID: 4265551
[TBL] [Abstract][Full Text] [Related]
40. THE RELATION OF ERYTHRITOL USAGE TO VIRULENCE IN THE BRUCELLAS.
WILLIAMS AE; KEPPIE J; SMITH H
J Gen Microbiol; 1964 Nov; 37():285-92. PubMed ID: 14247753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
